Medicis Pharma (MRX) Tops Q1 EPS by 3c, Issues Mixed Guidance for Q2
Tweet Send to a Friend
Medicis Pharma (NYSE: MRX) reports Q1 EPS of $0.15 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
